- Previous Close
0.1050 - Open
0.0000 - Bid --
- Ask 0.2000 x --
- Day's Range
0.1050 - 0.1050 - 52 Week Range
0.0300 - 0.8000 - Volume
400 - Avg. Volume
495 - Market Cap (intraday)
506,446 - Beta (5Y Monthly) 0.84
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Nirvana Life Sciences Inc. engages in the research and development of therapeutic products to address addiction. The company is headquartered in Vancouver, Canada.
nirvanalifescience.comRecent News: NIRV.CN
View MorePerformance Overview: NIRV.CN
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NIRV.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NIRV.CN
View MoreValuation Measures
Market Cap
506.45k
Enterprise Value
603.03k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-200.02%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-543.7k
Diluted EPS (ttm)
-0.2000
Balance Sheet and Cash Flow
Total Cash (mrq)
638
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
54.24k